F
Federico Cacciapuoti
Researcher at Seconda Università degli Studi di Napoli
Publications - 56
Citations - 1779
Federico Cacciapuoti is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Myocardial infarction & Internal medicine. The author has an hindex of 19, co-authored 50 publications receiving 1642 citations.
Papers
More filters
Journal ArticleDOI
Effects of Stress Hyperglycemia on Acute Myocardial Infarction: Role of inflammatory immune process in functional cardiac outcome
Raffaele Marfella,Mario Siniscalchi,Katherine Esposito,Ausilia Sellitto,Umberto De Fanis,Ciro Romano,Michele Portoghese,Silvio Siciliano,Francesco Nappo,Ferdinando Carlo Sasso,Nicola Mininni,Federico Cacciapuoti,Giacomo Lucivero,Riccardo Giunta,Mario Verza,Dario Giugliano +15 more
TL;DR: An increased inflammatory immune process seems a likely mechanism linking acute hyperglycemia to poor cardiac outcome in MI patients.
Journal ArticleDOI
Effect of Weight Loss on Cardiac Synchronization and Proinflammatory Cytokines in Premenopausal Obese Women
Raffaele Marfella,Katherine Esposito,Mario Siniscalchi,Federico Cacciapuoti,Francesco Giugliano,Domenico Labriola,Myriam Ciotola,Carmen Di Palo,Lucio Misso,Dario Giugliano +9 more
TL;DR: In obese women, ventricular dyssynchrony correlates with body fat, possibly through inappropriate secretion of cytokines, and weight loss represents a safe method for downregulating the inflammatory state and ameliorating cardiac function in obese women.
Journal ArticleDOI
Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis
Giovanni La Montagna,Federico Cacciapuoti,R. Buono,Daniela Manzella,Gianna Angela Mennillo,Alessandro Arciello,Gabriele Valentini,Giuseppe Paolisso +7 more
TL;DR: A significantly higher prevalence of IR is shown in RA patients and a significant association between IR and subclinical atherosclerosis is pointed out, driven primarily by exposure to steroid therapy.
Journal ArticleDOI
Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome
Raffaele Marfella,Clara Di Filippo,Michele Portoghese,Michelangela Barbieri,Franca Ferraraccio,Mario Siniscalchi,Federico Cacciapuoti,Francesco Rossi,Michele D'Amico,Giuseppe Paolisso +9 more
TL;DR: SREBP-1c may contribute to heart dysfunction by promoting lipid accumulation within myocytes in MS patients with AS; SREBP/peroxisome proliferator activated receptor-&ggr; protein may do it by increasing the levels of PPAR&ggR; protein.
Journal ArticleDOI
Silymarin in non alcoholic fatty liver disease.
TL;DR: It is indicated that silymarin appears to be effective to reduce the biochemical, inflammatory and ultrasonic indices of hepatic steatosis.